Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
1 minute read

Meta Materials Received New Purchase Order from Its G10 Central Bank Customer; New Purchase Order Represents An Additional $855K To The $4.3M Base Award Previously Received In September 2022-

By Charles Gross
February 16, 6:20 PM
Meta Materials Inc. (the "Company" or "META®") (NASDAQ: MMAT) today announced that it has been awarded a new purchase order for its authentication, nano-optic security business, which provides anti-counterfeiting features for currencies and government documents and authentication for brands.

MMAT

Read More
1 minute read

ALX Oncology Announced First Patient Dosed in ASPEN-07, a Phase 1 Study of Evorpacept for the Treatment of Patients with Urothelial Cancer

By Charles Gross
February 16, 8:06 AM
ALX Oncology Holdings Inc., ("ALX Oncology") (NASDAQ: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced the first patient has been dosed in the ASPEN-07 study evaluating evorpacept, a next generation CD47 blocker, in combination with PADCEV® (enfor

ALXO